Skip to Content

9 3 5213 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg)

Pill with imprint 9 3 5213 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 9 3 5213

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg 9 3 5213

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint:
9 3 5213
Strength:
12.5 mg / 7.5 mg
Color:
Yellow
Size:
10.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
lactose monohydrate
magnesium stearate
povidone k29/32
sodium bicarbonate
polyethylene glycol 3350
polyvinyl alcohol
magnesium silicate
titanium dioxide
FD&C Yellow No. 5
aluminum oxide
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0576 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide